Core Historical Financial Ratios
| CLB Stock | USD 20.28 0.72 3.68% |
Core Laboratories is presently reporting on over 115 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0022, PTB Ratio of 6.42 or Days Sales Outstanding of 89.98 will help investors to properly organize and evaluate Core Laboratories financial condition quickly.
Core |
About Core Financial Ratios Analysis
Core LaboratoriesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Core Laboratories investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Core financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Core Laboratories history.
Core Laboratories Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Core Laboratories stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Core Laboratories sales, a figure that is much harder to manipulate than other Core Laboratories NV multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Core Laboratories NV dividend as a percentage of Core Laboratories stock price. Core Laboratories dividend yield is a measure of Core Laboratories stock productivity, which can be interpreted as interest rate earned on an Core Laboratories investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from Core Laboratories' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Core Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At present, Core Laboratories' Price To Sales Ratio is projected to slightly decrease based on the last few years of reporting. The current year's PTB Ratio is expected to grow to 6.42, whereas Dividend Yield is forecasted to decline to 0.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.001787 | 0.001973 | 0.002266 | 0.002153 | Price To Sales Ratio | 2.18 | 1.92 | 1.62 | 2.7 |
Core Laboratories fundamentals Correlations
Click cells to compare fundamentals
Core Laboratories Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Core Laboratories fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 2.5 | 2.42 | 2.18 | 1.92 | 1.62 | 2.7 | |
| Dividend Yield | 0.0584 | 0.0106 | 0.001787 | 0.001973 | 0.002266 | 0.002153 | |
| Ptb Ratio | 9.17 | 15.6 | 6.38 | 4.97 | 3.67 | 6.42 | |
| Days Sales Outstanding | 71.87 | 62.32 | 75.16 | 79.68 | 88.11 | 89.98 | |
| Book Value Per Share | 4.11 | 1.7 | 3.5 | 4.08 | 4.92 | 2.64 | |
| Operating Cash Flow Per Share | 2.02 | 1.3 | 0.8 | 0.54 | 0.53 | 0.5 | |
| Stock Based Compensation To Revenue | 0.0312 | 0.0152 | 0.0406 | 0.0158 | 0.0274 | 0.019 | |
| Capex To Depreciation | 0.99 | 0.57 | 0.73 | 0.6 | 0.67 | 1.18 | |
| Pb Ratio | 9.17 | 15.6 | 6.38 | 4.97 | 3.67 | 6.42 | |
| Free Cash Flow Per Share | 1.52 | 1.03 | 0.5 | 0.32 | 0.3 | 0.29 | |
| Inventory Turnover | 10.33 | 10.37 | 8.5 | 6.8 | 5.8 | 9.22 | |
| Net Income Per Share | 2.3 | (2.18) | 0.43 | 0.42 | 0.79 | 1.25 | |
| Days Of Inventory On Hand | 35.33 | 35.2 | 42.92 | 53.7 | 62.95 | 66.1 | |
| Payables Turnover | 14.55 | 17.18 | 13.0 | 8.96 | 12.41 | 9.98 | |
| Sales General And Administrative To Revenue | 0.0719 | 0.0698 | 0.0939 | 0.0778 | 0.079 | 0.0527 | |
| Capex To Revenue | 0.031 | 0.0333 | 0.0244 | 0.0288 | 0.0209 | 0.0208 | |
| Cash Per Share | 0.3 | 0.25 | 0.31 | 0.38 | 0.32 | 0.46 | |
| Pocfratio | 18.66 | 20.38 | 28.06 | 37.63 | 33.26 | 17.66 | |
| Interest Coverage | 6.58 | 3.88 | 4.95 | 3.59 | 4.07 | 3.87 | |
| Payout Ratio | 0.96 | (0.13) | 0.093 | 0.0953 | 0.0509 | 0.0484 | |
| Capex To Operating Cash Flow | 0.25 | 0.21 | 0.37 | 0.41 | 0.43 | 0.44 | |
| Pfcf Ratio | 24.84 | 25.64 | 44.55 | 63.72 | 58.02 | 60.92 | |
| Days Payables Outstanding | 25.08 | 21.24 | 28.08 | 40.73 | 29.42 | 33.17 | |
| Income Quality | 0.96 | (0.6) | 1.81 | 1.27 | 0.67 | 0.93 | |
| Ev To Operating Cash Flow | 22.8 | 25.79 | 34.42 | 45.93 | 41.34 | 43.4 | |
| Pe Ratio | 16.38 | (12.15) | 52.03 | 48.28 | 22.48 | 37.57 | |
| Return On Tangible Assets | 0.24 | (0.28) | 0.0546 | 0.0527 | 0.0764 | 0.15 | |
| Ev To Free Cash Flow | 30.36 | 32.45 | 54.65 | 77.76 | 72.11 | 75.72 | |
| Earnings Yield | 0.061 | (0.0823) | 0.0192 | 0.0207 | 0.0445 | 0.0322 | |
| Net Debt To E B I T D A | 3.11 | (5.54) | 3.65 | 3.53 | 2.84 | 2.99 | |
| Tangible Book Value Per Share | (3.88) | (3.27) | (1.27) | (0.44) | 2.64 | 2.78 | |
| Receivables Turnover | 5.08 | 5.86 | 4.86 | 4.58 | 4.14 | 3.7 | |
| Graham Number | 14.57 | 9.13 | 5.81 | 6.21 | 9.23 | 7.73 | |
| Shareholders Equity Per Share | 4.11 | 1.7 | 3.5 | 4.08 | 4.82 | 2.62 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.316 | Dividend Share 0.04 | Earnings Share 0.54 | Revenue Per Share 11.158 | Quarterly Revenue Growth 0.072 |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.